Home Blog Page 475

nChain Partners With ATMPS Ltd. to Power Their World-Leading Cell and Gene Therapy Platform Hataali

0
nChain Partners With ATMPS Ltd. to Power Their World-Leading Cell and Gene Therapy Platform Hataali
ZUG, Switzerland - December 6, 2022 - (Newswire.com)

nChain, one of the largest global blockchain solutions companies, today announces its partnership with Hataali, the world-leading cell and gene therapy platform from ATMPS Ltd. The partnership will see nChain's data integrity platform allow Hataali to access the most scalable and secure blockchain unprecedented in the precision medicine space. 

Hataali, is the most advanced, regulatory-compliant, medical data-sharing platform for personalised medicines in the Advanced Therapy Medicinal Products sector. A unique and patented platform which provides the most comprehensive capabilities and functionality.

The Hataali Platform enables all partners in cell and gene therapies, from hospitals, to labs, to clinics and specialized couriers, to communicate and coordinate in real time. The platform is a configurable solution that enables partner organizations in personalised medicine to ensure that data required for optimal patient outcomes can be shared between parties in a secure, confidential, and regulatory-compliant manner using advanced distributed ledger technology. 

Hataali, the winner of the CPHI Pharma Award 2022 and the BioNow Award, is a true end-to-end solution that provides full transparency of the treatment process by keeping an immutable record of the full chain of custody, identity, and condition, demonstrating who is responsible and what has been done at each stage of the process. 

"The instant permissioning, interoperability and analysis of data, securely between healthcare institutions can greatly improve treatment effectiveness and ensure patient safety. There's so much innovation in personalised medicine right now, but the full benefits of those treatments can't be realized if our data infrastructure lags and cannot reach their full potential with our fully digital Hataali platform. Digitisation has become an increasingly important issue for organisations which have become cost conscious and looking for efficiency," said ATMPS Ltd. Founder and CEO Raja Sharif. 

He added, "We are excited to partner with nChain to integrate our platform providing access to their blockchain which we believe offers a best-in-class solution for data integrity which is paramount in healthcare, and even more so when it comes to precision medicine."

Since 2015, nChain has focused on developing solutions and inventions for enterprise blockchain use and satisfying the data management needs of all industries. nChain's data integrity platform provides enterprises and governments access to the benefits of tamper-proof documents, auditable logs, and integrated key management into APIs, allowing organizations to focus on collecting and analyzing data rather than securing it.

"The time has come for us to rethink the approach to patient data utility and security. The rails of the healthcare system deserve as much innovation as the treatments themselves, otherwise, healthcare providers won't be effective in delivering those treatments. We're proud to partner with an organization at the forefront of revolutionizing the administration of cell and gene therapies, and are committed to helping them make a difference in the lives of their patients," commented nChain's CEO Hakan Yuksel. 

About ATMPS

ATMPS Ltd provides patented advanced technical solutions for healthcare companies in the Advanced Therapy Medicines Products sector, including CAR-T treatments, stem cell and gene treatments. ATMPS have a unique distributed ledger solution which provides immutable and incorruptible data and automation capabilities. The solution is operational, configurable and can provide data analytics modules. It can integrate with all LIMS, MES and legacy solutions. It provides full chain of custody, identity and condition of samples, treatments and assets which it tracks. It also schedules and co-ordinates the supply chain participants, as well as giving them information at the same time, in real time, from a "single source of truth." For more information, please visit ATMPS' website at https://www.atmps.net.

About nChain  

nChain is a leading global blockchain technology company and recently voted one of the Top 100 most innovative firms in the world. We offer software, consulting services and IP licensing for clients in various industries looking to benefit from the security and scalability of the blockchain. Our mission is to secure the internet of value. Founded in 2015, nChain employs more than 250 staff, holds over 400 patents and are the developers of the Bitcoin SV Node software, Teranode, LiteClient and more.


Contact Information:
Carlos Leira
Director, Marketing & Communications
[email protected]


Press Release Service by Newswire.com

Original Source: nChain Partners With ATMPS Ltd. to Power Their World-Leading Cell and Gene Therapy Platform Hataali

Aronora Announces Clinical Data to Be Presented at the 64th American Society of Hematology Annual Meeting

0
Aronora Announces Clinical Data to Be Presented at the 64th American Society of Hematology Annual Meeting
Presentation to include clinical data from a phase 2 study of Gruticibart (AB023), a factor XI-targeted antibody being developed for the treatment and prevention of thrombosis and inflammation


Aronora logo

Aronora logo

PORTLAND, Ore. - December 6, 2022 - (Newswire.com)

Aronora Inc., a clinical-stage biotechnology company developing next-generation therapeutics for blood clotting diseases, announced today that clinical data from a phase 2 study of Gruticibart will be presented at the 64th American Society of Hematology (ASH) Annual Meeting, taking place in New Orleans, Dec. 10-13, 2022. 

Gruticibart (AB023) is a unique recombinant antibody that targets coagulation factor XI (FXI) and specifically inhibits FXI activation by factor XII without blocking its activation by thrombin. It has been specifically designed to treat and prevent blood clots without causing an increased bleeding risk. This phase 2 study evaluated the safety and efficacy of Gruticibart for the prevention of catheter-associated thrombosis in patients with cancer receiving chemotherapy. Additional information about the trial can be found at https://clinicaltrials.gov/ct2/show/NCT04465760.

Details of the oral presentation are as follows:
Title: Factor XI Inhibition for the Prevention of Catheter-Associated Thrombosis in Cancer Patients Undergoing Central Line Placement: A Phase 2 Clinical Trial
Publication Number: 518
Session: 332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Cancer-associated Thrombosis: Risk Stratification, Prevention, and Treatment
Session Date: Sunday, Dec. 11, 2022
Session Time: 12-1:30 p.m. 
Presentation Time: 12:15 p.m.

Abstracts are available via the ASH meeting website at https://www.hematology.org/meetings/annual-meeting/abstracts

Preclinical and early clinical development has been partially supported by the National Heart, Lung, and Blood Institute and National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) under award numbers R44HL106919, R44HL128016, and R44AI088937. This content is solely the responsibility of Aronora and does not necessarily represent the official views of the NIH.
For more information, please visit www.aronorabio.com.
 


Contact Information:
Erik Tucker
President & CEO
[email protected]
(503) 530-6842


Press Release Service by Newswire.com

Original Source: Aronora Announces Clinical Data to Be Presented at the 64th American Society of Hematology Annual Meeting

Mission Prepares Men for Workforce With New Suits From Advanced Advocacy and International Franchise Association

0
Mission Prepares Men for Workforce With New Suits From Advanced Advocacy and International Franchise Association

Men of the Mission receive new suits.

Central Union staff members, along with Andrew Kovalcin of Advanced Advocacy and David Smith from IFA, sit with the recipients of new suits from the Workforce Development and Education Program.

WASHINGTON - December 6, 2022 - (Newswire.com)

Today, Central Union Mission accepted hundreds of dry-cleaned suits, shirts, ties and shoes from Advanced Advocacy that were donated by local congressmen, senators, lobbyists and other DC professionals. For six years, Advanced Advocacy has consistently partnered with Central Union Mission to support the rehabilitation of our residents by supplying them with suits as they prepare to enter the workforce. International Franchise Association also played an integral role in the success of this suit drive.

Central Union staff members, along with Andrew Kovalcin of Advanced Advocacy and David Smith from IFA, sit with the recipients of new suits from the Workforce Development and Education Program

According to Joe Mettimano, Mission President & CEO, "When you look good, you feel good, and because of Advanced Advocacy and this amazing suit drive, our program graduates can head to their job interviews with confidence, equipped to display their new competence and skills."

According to Andrew Kovalcin of Advanced Advocacy, "We're dedicated to making a positive impact in people's lives as they make the journey from homelessness to self-sufficiency. Over the past six years, we have provided over one thousand business suits to eliminate one of the barriers men face when looking for employment. We've witnessed firsthand how equipping an individual with the right clothes can empower them in their transformation and be critical for their personal growth. The continued success of the annual suit drive shows that even a small company, combined with the help and donations of others, can make a big difference in someone's life and in our local community."

Beyond the core services of nutritious food and safe, clean beds, Central Union Mission offers several life-changing programs for men. The Restoration & Transformation Program helps them overcome addictions, reconcile with family, study the Bible and take responsibility for their attitudes and actions. Men can also join the Workforce Development & Education Program, which offers employment readiness training and soft skills, actual hands-on, wage-earning work in a mentored setting and finally, placement in an outside job and independent living situation.

"IFA is a proud partner with Advanced Advocacy to support Central Union Mission and all they are doing to help disadvantaged men in the greater D.C. community enter the workforce," said Rikki Amos, Executive Director of the IFA Foundation. "One suit can go a long way in helping establish confidence and pride, and we thank IFA member ZIPS Cleaners for making this effort possible. Serving the community is central to the work of local franchises, like ZIPS, and we are grateful for the opportunity to further this mission and give back to those around us."

For interviews and photos, please contact Deborah Chambers, VP, Development & Partnerships, at 202-534-9965 or [email protected].

About Central Union Mission:

Central Union Mission is a faith-based 501(c)(3) nonprofit organization and the oldest private social service agency in Washington, DC. In addition to its emergency shelter, which provides more than 60,000 bed-nights each year, the Mission operates holistic, Christ-centered transformation and workforce development programs for men, provides benefits for veterans, helps people overcome addictions, operates a food and clothing distribution center which provides food for over 4,000 people each month, runs a camp for underprivileged children, and offers a ministry to families and senior citizens. Charity Navigator has rated Central Union Mission a three-star charity, Candid awarded Central Union Mission a Gold Seal for our financial transparency, and GreatNonProfits has given Central Union Mission a Top-Rated award.

About Advanced Advocacy:

Advanced Advocacy is an independent advocacy and public affairs firm that specializes in issue campaigns, coalition management, third parties and alliances, grassroots activation and community engagement.

About The International Franchise Association:

Celebrating over 60 years of excellence, education, and advocacy, the International Franchise Association (IFA) is the world's oldest and largest organization representing franchising worldwide. IFA works through its government relations and public policy, media relations, and educational programs to protect, enhance and promote franchising and the approximately 775,000 franchise establishments that support nearly 8.2 million direct jobs, $787.7 billion of economic output for the U.S. economy, and almost 3 percent of the Gross Domestic Product (GDP). IFA members include franchise companies in over 300 different business format categories, individual franchisees, and companies that support the industry in marketing, law, technology, and business development.


Contact Information:
Rev Deborah Chambers
Vice-President, Development and Partnerships
[email protected]
202-534-9965


Press Release Service by Newswire.com

Original Source: Mission Prepares Men for Workforce With New Suits From Advanced Advocacy and International Franchise Association

The Passport Index reveals that Despite Conflict in Europe and Global Border Anxieties, 99.5% of the World Experiences Growth in Global Mobility in 2022

0
The Passport Index reveals that Despite Conflict in Europe and Global Border Anxieties, 99.5% of the World Experiences Growth in Global Mobility in 2022

Passport Index app

The world's passports in your pocket

MONTREAL - December 6, 2022 - (Newswire.com)

The Passport Index has published its latest update today, showing that global mobility is rising, despite the eruption of conflict in Europe and growing tensions over borders. Though the world continues to feel the aftershocks of the pandemic, surprisingly, traveling has never been easier, with steady growth in passport power, a trend that is predicted to continue into 2023. Across these findings, what stands out, in particular, is that the passport of almost every single country around the world became more powerful this year. 

 
Country Change in mobility score (2022)
Malaysia +31
St. Vincent and the Grenadines +31
Guatemala +30
Micronesia +30
Brazil +30
Palau +30
Solomon Islands +29
Brunei +29
Barbados +29
Saint Lucia +29

Table 1: Top 10 changes in mobility score   

 
Country Change in mobility score (2022)
Armenia +6
Tanzania +6
Pakistan +6
Lebanon +5
Burundi +5
Bangladesh +4
Syria +4
Libya +4
Afghanistan +4
Vanuatu -7

Table 2: Bottom 10 changes in mobility score

This may be surprising given the ongoing war in Ukraine in combination with systemic pressures on international supply chains. However, the latest data from the Passport Index indicates strong mobility growth. Whilst the removal of Covid-19 restrictions has certainly played a role, countries around the world have also been keen to reap the economic benefits offered by enabling easy movement around the world. Passport power around the world has increased by an average of 16 points this year, with just one country, Vanuatu, seeing its mobility score fall. This was due to the suspension of their visa waiver scheme with the European Union. The fact the power of their passport has fallen by just seven points despite this indicates strong growth elsewhere.

 
 
 
Individual Passport Power Rank (2022) Country Mobility Score Visa-Free Entry Visa-On-Arrival Visa Required Percentage Visa-Free and Visa-On-Arrival
1 United Arab Emirates 180 121 59 18 91%
2 Germany 173 127 46 25 87%
3 Sweden 173 126 47 25 87%
4 Finland 173 126 47 25 87%
5 Luxembourg 173 126 47 25 87%
6 Spain 173 126 47 25 87%
7 France 173 126 47 25 87%
8 Italy 173 126 47 25 87%
9 Netherlands 173 125 48 25 87%
10 Austria 171 123 48 25 86%

Table 3: 10 most powerful passports (2022)

Not only are passports becoming more powerful, but countries are becoming increasingly open to visa-free arrivals. Prior to the pandemic, the average growth of the World Openness Score was 3.6% a year. After the impact of the pandemic, the score experienced a decline of 65%, falling from 21,360 to 12,944. Since then, growth has rebounded spectacularly, with an average growth rate of 18.8%. At the end of 2022, this score now stands at 21,695; the highest it's ever been. 

The finding of general growth in global mobility does, however, obscure some of the winners and losers this year. The UK falls into this latter category: though it has seen its global mobility score rise again, its year-on-year gains have stagnated relative to other European states, such as France. This trend appears set to continue as the UK struggles to strike the visa agreements achieved by states within the EU. This is largely attributable to the consequences of leaving the common market.

Alongside the rise in passport power around the world, countries, in general, have become more welcoming, with a greater number of countries accepting more passports visa-free, with visa on arrival, or with electronic travel agreement. Nowhere is this more apparent than in Africa, where many countries, especially those in Central and West Africa, have continued to create a travel environment that is accessible to all, no matter the nationality on your passport. The Passport Index's Welcoming Countries Rank shows that 15 of the 23 most welcoming countries in the world are found in Africa, welcoming 198 countries out of 199. 

Hrant Boghossian, Co-founder of the Passport Index, commented that "the rise in passport power that we have seen this year brings great cause for optimism. The world has surpassed the benchmark of 'openness' set prior to the pandemic, and there are strong indicators that this upward trend is here to stay. It is particularly encouraging to see such growth at a time of heightened geopolitical tension and economic turmoil, indicating that countries agree that a world with fewer borders has the potential to address some of the defining challenges of the 21st century."


Contact Information:
Jasper Rose
Consultant, The Agency Partnership
[email protected]


Press Release Service by Newswire.com

Original Source: The Passport Index reveals that Despite Conflict in Europe and Global Border Anxieties, 99.5% of the World Experiences Growth in Global Mobility in 2022

Redox and Let’s Talk Interactive Partner to Expand Access to Healthcare

0
Redox and Let’s Talk Interactive Partner to Expand Access to Healthcare
Tech firms unite to address inefficiencies in virtual care integration

CHARLOTTE, N.C. - December 6, 2022 - (Newswire.com)

Today, Redox, the company setting the stage for composable healthcare, has partnered with Let's Talk Interactive, a technology company that develops virtual care solutions to make healthcare more accessible. Together Let's Talk Interactive (LTI) and Redox are addressing inefficiencies in virtual care and making the EHR/EMR integration experience seamless for healthcare systems.

Virtual care solutions enable healthcare systems to extend access to care, overcoming clinician shortages and burnout, while maintaining continuity of care and improving patient outcomes. However, a key barrier to telehealth deployment for many health systems is the ability to find an efficient path to telehealth implementation. On average, it takes hospitals 23 months to go from identifying the need for digital innovation to scaling that solution to meet the need (AMA). Integrating a new virtual care solution into a health system's current EHR alone can take 3-4 months.

LTI and Redox are addressing these inefficiencies head-on, cutting the virtual care integration time in half to 30 to 60 days. LTI's next-generation enterprise telehealth solution, TrustVideo, leverages Redox's integration expertise with any EHR/EMR system, resulting in the platform's efficient integration with existing workflows of healthcare systems. This enables healthcare systems to integrate virtual care faster than ever before and scale it across the entire system efficiently with no additional cost. 

"Virtual care has seen an unprecedented rise in the past couple of years," explains Redox VP of Product Bryan Dunn. "Patients and clinicians see the value of having virtual experiences composed just for them. At Redox, we're glad to help LTI make that happen at scale."

"We are thrilled to announce our partnership with Redox, a best-in-class partner whose integration expertise is unmatched," said Arthur Cooksey, CEO and Founder of Let's Talk Interactive. "Our collaboration has resulted in one of the most unique telehealth technology platforms on the market that can serve any medical use case. Together, we are serving our mission which is to make healthcare accessible for all people." 

About Redox 
Payers, providers, digital health companies, and other healthcare entities use Redox to produce differentiated experiences for patients and clinicians. Connecting to more than 30,000 healthcare organizations, Redox provides a composable software experience across the healthcare ecosystem. With our single API, product teams are empowered to build whatever they can imagine. Redox accelerates innovations that make healthcare data more useful than ever before.

About Let's Talk Interactive, Inc.
Let's Talk Interactive, Inc. (LTI) is an innovator in telehealth that has developed the most complete and configurable HIPAA-compliant telemedicine platform in the world.  

Through proprietary telehealth software, medical hardware, and provider network solutions, LTI gives those in need instant access to care. Headquartered in Charlotte, NC, the company ranked No. 496 on the 2022 Inc. 5000 annual list of fastest-growing companies. For more information about Let's Talk Interactive, visit visit www.letstalkinteractive.com.


Contact Information:
Caitlin Wolf
PR and Communications Executive, LTI
[email protected]
980-220-3777

Miona Short
Redox media contact
[email protected]


Press Release Service by Newswire.com

Original Source: Redox and Let's Talk Interactive Partner to Expand Access to Healthcare

A Game Changer Book for Men Facing Cancer

0
A Game Changer Book for Men Facing Cancer
Founder of Man Up to Cancer Launches New Book to Address the Unique Challenges of Men with Cancer

CAPE ELIZABETH, Maine - December 6, 2022 - (Newswire.com)

Not many men open up about what it's really like to face cancer - no filters, no pretense. But Trevor Maxwell, a husband and father of two young girls and founder of Man Up to Cancer, is changing that story. 

In March 2018, Maxwell was diagnosed with Stage IV colon cancer and has since undergone five major surgeries and more than 50 rounds of chemotherapy and immunotherapy. 

In Maxwell's new book, "Open Heart, Warrior Spirit: A Man's Guide to Living with Cancer," he tells the story of one patient's quest to create a 'wolfpack' for men with cancer. The book not only explains why men go into their man caves when facing a cancer diagnosis but provides a roadmap for surviving and thriving through treatment. 

"For men with cancer, there's an old road to travel, and you're supposed to walk alone. Don't show pain. Don't burden others. Don't talk about it," Maxwell said. "The trouble is, isolation during cancer leads to mental health problems and worse medical outcomes. This book offers a new road for men facing cancer where we share the burden, accept help, and give help along the way. It's a wolfpack mentality. We're stronger and smarter as a pack than we are as lone wolves." 

Patrick Dempsey, known worldwide for his iconic television and film roles, met Maxwell in 2019 through the Dempsey Center, which provides counseling, nutrition, exercise, and other services to cancer patients and their families. Dempsey's endorsement appears on the back cover of Maxwell's book. 

"Trevor writes with authenticity, generosity, and heart. For men facing cancer and the people who love them, this book is a game changer," said Patrick Dempsey. 

Maxwell also founded "Man Up to Cancer," a purpose-driven company and support community, with a mission to inspire men to avoid isolation during the cancer journey. Through this community, the hearts of countless men across the country and around the world have been opened, helping them share their fears and burdens so they can find their warrior spirits and better fight their disease. Since its inception, Man Up to Cancer has grown into a thriving international community with a popular podcast and sought-after swag. The testimonials from those who have found Man Up to Cancer speak to the group's effect on their lives. 

"Open Heart, Warrior Spirit: A Man's Guide to Living with Cancer" is currently available through Amazon and can be accessed here

Maxwell resides in Cape Elizabeth, Maine, with his wife and two daughters. 

About Man Up to Cancer

Man Up to Cancer inspires men to connect and avoid isolation during their cancer journeys. Founded in 2020 by a Stage IV colon cancer survivor, the purpose-driven company and online community offers a podcast, annual retreat, and Facebook group with more than 2,000 men impacted by cancer. Man Up to Cancer also operates a Chemo Backpack program, sending backpacks filled with practical items to men going through chemotherapy. 

For more information, visit www.manuptocancer.com and follow us on Facebook and Instagram

+++


Contact Information:
Kim King
[email protected]
(805)410-0180
Related Images


Press Release Service by Newswire.com

Original Source: A Game Changer Book for Men Facing Cancer

Rarebreed Announces Partnership With Blend

0
Rarebreed Announces Partnership With Blend
First veterinary hospitals to be certified in diversity, equity, inclusion, and belonging

PORTLAND, Maine - December 5, 2022 - (Newswire.com)

Rarebreed Veterinary Partners, a thriving community of veterinary hospitals whose goal is to deliver exceptional patient care, outstanding client service, and an amazing employee experience, announces a partnership with Blend VetMed. Blend, a veterinary hospital certification program designed to train veterinary teams in diversity, equity, inclusion, and belonging (DEIB), is the first of its kind to create an inclusive workplace culture geared towards fostering environments of belonging for teams and clients. The Rarebreed-Blend partnership signifies a major milestone as the first community of veterinary hospitals prepares to become Blend-certified.

"As the demographics of our country evolve in its diversity, the changes will be reflected within the populations of our veterinary workforce and among pet owners," said Dr. Niccole Bruno, CEO and founder of Blend. "Therefore, it is essential for veterinary organizations to begin prioritizing DEIB training, incorporating DEIB practices into their daily routine, and providing tools that aid in embracing and cultivating a sustainable hospital culture."

A 2013 article in The Atlantic referenced veterinary medicine as the least diverse medical profession in the United States, and the 2021 US Bureau of Labor & Statistics reported that less than 2% black, 4.7% Latin X, and 5.6% Asian populations were represented. Blend chief operating officer, Dr. Genine Ervin-Smith, stated, "Blend is a program that is necessary for all professions, and I'm thrilled that we're starting with the field of veterinary medicine, which is near and dear to our hearts."

Rarebreed Veterinary Partners was founded in 2018 in Portland, Maine, to reimagine the veterinary experience. Rarebreed is a thriving community of veterinary hospitals that goes the extra mile to create exceptional veterinary experiences, one partner practice and team member at a time. When asked about the partnership, Sarah Mills, Rarebreed senior director of marketing and communications, said, "As a woman who has been a leader in the veterinary industry for over a decade, I am proud to use my voice to advocate for big industry changes. I want our care teams to be represented by the best and brightest applicants who are not only filled with a sense of belonging but also know they have a voice at our Rarebreed table."

With over 120 locations across the Northeast, Florida, and Virginia, Rarebreed is committed to universal training to sustain wellness, inclusion, and belonging in the workplace. Rarebreed CEO, Dan Espinal, commented, "I was raised in a multi-ethnic family as a first-generation American whose first language was not English. I remember from an early age what it felt like to not belong. My goal is to ensure that people who enter our practices, whether as an employee or a client, know that we are committed to changing the dialogue. I am confident that Rarebreed's partnership with Blend is going to do just that."

Rarebreed's 2023 partnership with Blend reflects its commitment to the transformational change it strives to create within the veterinary profession and beyond.
 

##

About Rarebreed

Rarebreed Veterinary Partners is a thriving community of veterinary hospitals that goes the extra mile to create exceptional work experiences, one partnership at a time. We pride ourselves on building trusted, lasting relationships with our partner hospitals, with a mission to provide exceptional patient care, outstanding client service and an amazing work experience. We continue to build a broad network of practices that value healthcare teams by offering them the innovation and tools necessary to grow, improve and reimagine the veterinary experience. For more information, visit www.rarebreedvet.com.

Rarebreed is the registered service mark of Rarebreed Veterinary Partners. 


Contact Information:
Melissa Lucas
Senior Communications, PR & Events Marketing Manager
[email protected]
(781) 534-2714


Press Release Service by Newswire.com

Original Source: Rarebreed Announces Partnership With Blend

Switch Launches New Membership to Make Luxury Handbags Accessible

0
Switch Launches New Membership to Make Luxury Handbags Accessible
The LA-based startup aims to become the "leading luxury accessory rental platform."

LOS ANGELES - December 5, 2022 - (Newswire.com)

Switch, the venture-backed luxury accessory rental startup, has expanded into handbags. Today marks the launch of Switch's new membership tier, 'Select,' which features handbags by iconic designers like Chanel, Hermes, and Louis Vuitton. The Select collection, which consists of accessories with an average retail value of $4000, also includes jewelry by the likes of Cartier and Van Cleef & Arpels. Select, which starts at $195/month, lets members swap out their items whenever they want, as often as they want, with an option to buy their favorites at a discounted price.

"The launch of Switch Select brings us one step closer to our mission of transforming the way consumers experience luxury," said Adriel Darvish, Co-Founder and CEO of Switch. "Our vision is a world where luxury isn't merely something you aspire to own but rather an experience you can enjoy without limits."

Switch, which counts Human Capital, Maveron, Soma Ventures, and the founders of Sweetgreen and Tinder among its early investors, had until now been focused on jewelry. Members will continue to have access to luxury designer jewelry through its Core memberships, which start at $45 per month.

Switch President and Co-Founder Liana Kadisha Cohn added that "the expansion into handbags has been in our plans since Switch's early days. It's a natural extension of our offering as we look to become the leading luxury accessory rental platform."

Switch (joinswitch.com) launched a waitlist for Select in June, which already has thousands of sign-ups. The company will admit new members to Select on a rolling basis as it races to keep up with demand.

ABOUT SWITCH

Switch is on a mission to revolutionize luxury by providing unparalleled access to designer accessories. For a monthly fee starting at $45/month, members can borrow from an ever-expanding trove of designer jewelry and handbags and exchange then any time, as often as they wish. Members also earn credit each month, which they can use towards purchasing their favorites at a discount. Switch is the grown-up's dress-up trunk-a place for play, discovery, and owning your style (albeit not literally).


Contact Information:
Natallie Mashian
Head of PR and Partnerships
[email protected]
(310) 666-0641


Press Release Service by Newswire.com

Original Source: Switch Launches New Membership to Make Luxury Handbags Accessible

Chowis’ AI Skin Diagnosis Solution ‘mySkin F.A.I.N’ Gets Named in CES 2023 Innovation Award

0
Chowis’ AI Skin Diagnosis Solution ‘mySkin F.A.I.N’ Gets Named in CES 2023 Innovation Award

mySkin F.A.I.N

Chowis mySkin F.A.I.N

SEOUL, South Korea - December 5, 2022 - (Newswire.com)

Chowis, a Skin and Hair & Scalp Diagnosis System Company, has been named in the "CES 2023 Innovation Award" for its AI full face diagnosis solution, "MySkin F.A.I.N".

The CES Innovation Award is given to products with superior technology and innovation through a pre-evaluation of entries ahead of the CES event, the world's largest IT and home appliances exhibition held in Las Vegas every January.

Chowis' mySkin F.A.I.N won in the "Digital Health" category as an AI full-face skin diagnosis solution that analyzes skin using AI algorithm technology. MySkin F.A.I.N. is a small and portable device that can be used via a clip-on mechanism on a mobile phone or tablet and utilizes optimized lighting to analyze a total of 12 skin analysis parameters, providing more accurate optical analysis results.

Prior to winning the CES Innovation Awards, Chowis was awarded with Good Design (GD) by the Department of Trade, Industry, and Energy for reducing plastic consumption by 85%, being less than half the size of a smartphone and boasting overwhelming versatility.

Choi Won Suk, CEO of Chowis, said: "The past few years have brought a lot of changes in the health and beauty industry. Chowis adapts and innovates in order to address these changing needs, and we believe that our solutions, especially Myskin FAIN, match the present and future needs in skin analysis. This award serves as another milestone, and we will continue to work diligently to achieve our corporate mission of providing the best products and services to our customers around the world." 


Contact Information:
Lee Ja Yeong
Manager
[email protected]


Press Release Service by Newswire.com

Original Source: Chowis' AI Skin Diagnosis Solution 'mySkin F.A.I.N' Gets Named in CES 2023 Innovation Award

AQuity Appoints Chris Rigg to Board of Directors

0
AQuity Appoints Chris Rigg to Board of Directors

AQuity Logo

AQuity Logo

CARY, N.C. - December 5, 2022 - (Newswire.com)

AQuity Solutions today announced the appointment of Chris Rigg to the company's board of directors. Chris brings over 20 years of healthcare leadership experience and currently serves as CFO of the Commercial and Specialty Business Division of Elevance Health, formerly Anthem. Prior to Elevance Health, Chris served in various healthcare equity analyst leadership roles within Merrill Lynch, Deutsche Bank, and Susquehanna International. Chris is an MBA graduate of the Stern School of Business at NYU.

Leading healthcare provider organizations rely on AQuity as their Virtual Partners in Care, alleviating the clinical documentation capture burdens inherent to the electronic medical record, while ensuring proper clinical coding and revenue capture.  

"We are delighted to welcome Chris to AQuity Solutions during this period of rapid growth and scale," shared Kashyap Joshi, CEO. "As we accelerate our growth initiatives and strategic transactions, Chris's experience will help us optimize our organic and inorganic investments."

"Chris brings vast expertise as we evaluate growth opportunities and build upon our market leading position in the clinical documentation capture and medical coding space," said Rick Kneipper, Chairman of AQuity's board of directors. Chris fills the board seat vacated by Matthew Sheahan, who recently joined Silver Point Capital as Head of Credit. "We thank Matthew for his valuable contributions to AQuity over the past three years."  

"AQuity's client distribution network includes 21 of the Top 25 and over half of the Top 250 largest health systems in the United States, offering enterprise value creation at scale," said Rigg. "I am honored to join the AQuity team during this period of rapid growth, making a difference in the financial wellness of health care systems as well as in the lives of providers and the patients they serve."

About AQuity Solutions

Headquartered in Cary, NC, AQuity employs over 7,500 clinical documentation and medical coding professionals across the United States, India, Australia, Canada, and the U.K. With over 45 years of experience in service and technology solutions for healthcare, AQuity is recognized year after year by KLAS and Black Book as a leading vendor in multiple disciplines. AQuity is privately held. https://aquitysolutions.com/


Contact Information:
Dale Kivi
Senior Director of Communications
[email protected]
804.339.9017


Press Release Service by Newswire.com

Original Source: AQuity Appoints Chris Rigg to Board of Directors